CalciMedica (CALC) Earnings Date & Reports

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CALC is expected to report earnings to fall 13.33% to -195 cents per share on November 18

Q3'26

Est.

$-1.95

Q2'26

Missed

by $0.95

Q1'26

Beat

by $0.81

Q4'25

Beat

by $1.38

Q3'25

Beat

by $1.21

The last earnings report on August 11 showed earnings per share of -225 cents, missing the estimate of -129 cents. With 12.23K shares outstanding, the current market capitalization sits at 11.47M.

View a ticker or compare two or three

CALC

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CALC